Table of Content

1 Prevent Meningitis Vaccine Market Overview
1.1 Product Overview and Scope of Prevent Meningitis Vaccine
1.2 Prevent Meningitis Vaccine Segment by Type
1.2.1 Global Prevent Meningitis Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Meningococcal A Vaccine
1.2.3 Meningococcal AC Vaccine
1.2.4 Meningococcal B Vaccine (MenB)
1.2.5 Meningococcal Conjugate Vaccine (MenaCWY)
1.3 Prevent Meningitis Vaccine Segment by Application
1.3.1 Global Prevent Meningitis Vaccine Market Value by Application: (2024-2034)
1.3.2 Baby
1.3.3 Child
1.3.4 Teenager
1.3.5 Others
1.4 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Prevent Meningitis Vaccine Revenue 2024-2034
1.4.2 Global Prevent Meningitis Vaccine Sales 2024-2034
1.4.3 Global Prevent Meningitis Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Prevent Meningitis Vaccine Market Competition by Manufacturers
2.1 Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Prevent Meningitis Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Prevent Meningitis Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prevent Meningitis Vaccine, Product Type & Application
2.7 Prevent Meningitis Vaccine Market Competitive Situation and Trends
2.7.1 Prevent Meningitis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prevent Meningitis Vaccine Players Market Share by Revenue
2.7.3 Global Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prevent Meningitis Vaccine Retrospective Market Scenario by Region
3.1 Global Prevent Meningitis Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Prevent Meningitis Vaccine Global Prevent Meningitis Vaccine Sales by Region: 2024-2034
3.2.1 Global Prevent Meningitis Vaccine Sales by Region: 2024-2024
3.2.2 Global Prevent Meningitis Vaccine Sales by Region: 2024-2034
3.3 Global Prevent Meningitis Vaccine Global Prevent Meningitis Vaccine Revenue by Region: 2024-2034
3.3.1 Global Prevent Meningitis Vaccine Revenue by Region: 2024-2024
3.3.2 Global Prevent Meningitis Vaccine Revenue by Region: 2024-2034
3.4 North America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.4.1 North America Prevent Meningitis Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Prevent Meningitis Vaccine Sales by Country (2024-2034)
3.4.3 North America Prevent Meningitis Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prevent Meningitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Prevent Meningitis Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Prevent Meningitis Vaccine Sales by Country (2024-2034)
3.5.3 Europe Prevent Meningitis Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prevent Meningitis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Prevent Meningitis Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Prevent Meningitis Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Prevent Meningitis Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Prevent Meningitis Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Prevent Meningitis Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Prevent Meningitis Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prevent Meningitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Prevent Meningitis Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prevent Meningitis Vaccine Sales by Type (2024-2034)
4.1.1 Global Prevent Meningitis Vaccine Sales by Type (2024-2024)
4.1.2 Global Prevent Meningitis Vaccine Sales by Type (2024-2034)
4.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Prevent Meningitis Vaccine Revenue by Type (2024-2034)
4.2.1 Global Prevent Meningitis Vaccine Revenue by Type (2024-2024)
4.2.2 Global Prevent Meningitis Vaccine Revenue by Type (2024-2034)
4.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Prevent Meningitis Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Prevent Meningitis Vaccine Sales by Application (2024-2034)
5.1.1 Global Prevent Meningitis Vaccine Sales by Application (2024-2024)
5.1.2 Global Prevent Meningitis Vaccine Sales by Application (2024-2034)
5.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Prevent Meningitis Vaccine Revenue by Application (2024-2034)
5.2.1 Global Prevent Meningitis Vaccine Revenue by Application (2024-2024)
5.2.2 Global Prevent Meningitis Vaccine Revenue by Application (2024-2034)
5.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Prevent Meningitis Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Merck Prevent Meningitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Novartis Prevent Meningitis Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Corporation Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
6.6.5 Sanofi Pasteur Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 JN International Medical Corporation
6.8.1 JN International Medical Corporation Corporation Information
6.8.2 JN International Medical Corporation Description and Business Overview
6.8.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
6.8.5 JN International Medical Corporation Recent Developments/Updates
6.9 Serum Institute of India
6.9.1 Serum Institute of India Corporation Information
6.9.2 Serum Institute of India Description and Business Overview
6.9.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
6.9.5 Serum Institute of India Recent Developments/Updates
6.10 Bio-Med
6.10.1 Bio-Med Corporation Information
6.10.2 Bio-Med Description and Business Overview
6.10.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
6.10.5 Bio-Med Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Prevent Meningitis Vaccine Description and Business Overview
6.11.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Wyeth Pharmaceuticals, Inc
6.12.1 Wyeth Pharmaceuticals, Inc Corporation Information
6.12.2 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Description and Business Overview
6.12.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
6.12.5 Wyeth Pharmaceuticals, Inc Recent Developments/Updates
6.13 Walvax
6.13.1 Walvax Corporation Information
6.13.2 Walvax Prevent Meningitis Vaccine Description and Business Overview
6.13.3 Walvax Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Walvax Prevent Meningitis Vaccine Product Portfolio
6.13.5 Walvax Recent Developments/Updates
6.14 Zhejiang Tianyuan
6.14.1 Zhejiang Tianyuan Corporation Information
6.14.2 Zhejiang Tianyuan Prevent Meningitis Vaccine Description and Business Overview
6.14.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
6.14.5 Zhejiang Tianyuan Recent Developments/Updates
6.15 Beijing Tiantan Biological
6.15.1 Beijing Tiantan Biological Corporation Information
6.15.2 Beijing Tiantan Biological Prevent Meningitis Vaccine Description and Business Overview
6.15.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
6.15.5 Beijing Tiantan Biological Recent Developments/Updates
6.16 China National Biotec Group
6.16.1 China National Biotec Group Corporation Information
6.16.2 China National Biotec Group Prevent Meningitis Vaccine Description and Business Overview
6.16.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.16.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
6.16.5 China National Biotec Group Recent Developments/Updates
6.17 Tianjin CanSino Biotechnology
6.17.1 Tianjin CanSino Biotechnology Corporation Information
6.17.2 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Description and Business Overview
6.17.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
6.17.5 Tianjin CanSino Biotechnology Recent Developments/Updates
6.18 Zhifei
6.18.1 Zhifei Corporation Information
6.18.2 Zhifei Prevent Meningitis Vaccine Description and Business Overview
6.18.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
6.18.5 Zhifei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prevent Meningitis Vaccine Industry Chain Analysis
7.2 Prevent Meningitis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prevent Meningitis Vaccine Production Mode & Process
7.4 Prevent Meningitis Vaccine Sales and Marketing
7.4.1 Prevent Meningitis Vaccine Sales Channels
7.4.2 Prevent Meningitis Vaccine Distributors
7.5 Prevent Meningitis Vaccine Customers
8 Prevent Meningitis Vaccine Market Dynamics
8.1 Prevent Meningitis Vaccine Industry Trends
8.2 Prevent Meningitis Vaccine Market Drivers
8.3 Prevent Meningitis Vaccine Market Challenges
8.4 Prevent Meningitis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prevent Meningitis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Prevent Meningitis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Prevent Meningitis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prevent Meningitis Vaccine Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Prevent Meningitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Prevent Meningitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prevent Meningitis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Prevent Meningitis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prevent Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prevent Meningitis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Prevent Meningitis Vaccine Sales by Region (2024-2024) & (K Units)
Table 18. Global Prevent Meningitis Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Prevent Meningitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Prevent Meningitis Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Prevent Meningitis Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Prevent Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Prevent Meningitis Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Prevent Meningitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 27. North America Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Prevent Meningitis Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Prevent Meningitis Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Prevent Meningitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 32. Europe Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Prevent Meningitis Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Prevent Meningitis Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Prevent Meningitis Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Prevent Meningitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Prevent Meningitis Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Prevent Meningitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Prevent Meningitis Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Prevent Meningitis Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Prevent Meningitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Prevent Meningitis Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Prevent Meningitis Vaccine Sales (K Units) by Type (2024-2024)
Table 51. Global Prevent Meningitis Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Prevent Meningitis Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Prevent Meningitis Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2024-2024)
Table 59. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Prevent Meningitis Vaccine Sales (K Units) by Application (2024-2024)
Table 61. Global Prevent Meningitis Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Prevent Meningitis Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Prevent Meningitis Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2024-2024)
Table 69. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. GSK Prevent Meningitis Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Pfizer Prevent Meningitis Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Merck Prevent Meningitis Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Novartis Prevent Meningitis Vaccine Product
Table 89. Novartis Recent Developments/Updates
Table 90. Baxter International Corporation Information
Table 91. Baxter International Description and Business Overview
Table 92. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Baxter International Prevent Meningitis Vaccine Product
Table 94. Baxter International Recent Developments/Updates
Table 95. Sanofi Pasteur Corporation Information
Table 96. Sanofi Pasteur Description and Business Overview
Table 97. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Sanofi Pasteur Prevent Meningitis Vaccine Product
Table 99. Sanofi Pasteur Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. CSL Behring Prevent Meningitis Vaccine Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. JN International Medical Corporation Corporation Information
Table 106. JN International Medical Corporation Description and Business Overview
Table 107. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. JN International Medical Corporation Prevent Meningitis Vaccine Product
Table 109. JN International Medical Corporation Recent Developments/Updates
Table 110. Serum Institute of India Corporation Information
Table 111. Serum Institute of India Description and Business Overview
Table 112. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Serum Institute of India Prevent Meningitis Vaccine Product
Table 114. Serum Institute of India Recent Developments/Updates
Table 115. Bio-Med Corporation Information
Table 116. Bio-Med Description and Business Overview
Table 117. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Bio-Med Prevent Meningitis Vaccine Product
Table 119. Bio-Med Recent Developments/Updates
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Business Overview
Table 122. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Hualan Bio Prevent Meningitis Vaccine Product
Table 124. Hualan Bio Recent Developments/Updates
Table 125. Wyeth Pharmaceuticals, Inc Corporation Information
Table 126. Wyeth Pharmaceuticals, Inc Description and Business Overview
Table 127. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product
Table 129. Wyeth Pharmaceuticals, Inc Recent Developments/Updates
Table 130. Walvax Corporation Information
Table 131. Walvax Description and Business Overview
Table 132. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Walvax Prevent Meningitis Vaccine Product
Table 134. Walvax Recent Developments/Updates
Table 135. Zhejiang Tianyuan Corporation Information
Table 136. Zhejiang Tianyuan Description and Business Overview
Table 137. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Zhejiang Tianyuan Prevent Meningitis Vaccine Product
Table 139. Zhejiang Tianyuan Recent Developments/Updates
Table 140. Beijing Tiantan Biological Corporation Information
Table 141. Beijing Tiantan Biological Description and Business Overview
Table 142. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Beijing Tiantan Biological Prevent Meningitis Vaccine Product
Table 144. Beijing Tiantan Biological Recent Developments/Updates
Table 145. China National Biotec Group Corporation Information
Table 146. China National Biotec Group Description and Business Overview
Table 147. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. China National Biotec Group Prevent Meningitis Vaccine Product
Table 149. China National Biotec Group Recent Developments/Updates
Table 150. Tianjin CanSino Biotechnology Corporation Information
Table 151. Tianjin CanSino Biotechnology Description and Business Overview
Table 152. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product
Table 154. Tianjin CanSino Biotechnology Recent Developments/Updates
Table 155. Zhifei Corporation Information
Table 156. Zhifei Description and Business Overview
Table 157. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Zhifei Prevent Meningitis Vaccine Product
Table 159. Zhifei Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Prevent Meningitis Vaccine Distributors List
Table 163. Prevent Meningitis Vaccine Customers List
Table 164. Prevent Meningitis Vaccine Market Trends
Table 165. Prevent Meningitis Vaccine Market Drivers
Table 166. Prevent Meningitis Vaccine Market Challenges
Table 167. Prevent Meningitis Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prevent Meningitis Vaccine
Figure 2. Global Prevent Meningitis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Prevent Meningitis Vaccine Market Share by Type in 2022 & 2034
Figure 4. Meningococcal A Vaccine Product Picture
Figure 5. Meningococcal AC Vaccine Product Picture
Figure 6. Meningococcal B Vaccine (MenB) Product Picture
Figure 7. Meningococcal Conjugate Vaccine (MenaCWY) Product Picture
Figure 8. Global Prevent Meningitis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Prevent Meningitis Vaccine Market Share by Application in 2022 & 2034
Figure 10. Baby
Figure 11. Child
Figure 12. Teenager
Figure 13. Others
Figure 14. Global Prevent Meningitis Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Prevent Meningitis Vaccine Market Size (2024-2034) & (US$ Million)
Figure 16. Global Prevent Meningitis Vaccine Sales (2024-2034) & (K Units)
Figure 17. Global Prevent Meningitis Vaccine Average Price (US$/Unit) & (2024-2034)
Figure 18. Prevent Meningitis Vaccine Report Years Considered
Figure 19. Prevent Meningitis Vaccine Sales Share by Manufacturers in 2022
Figure 20. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Prevent Meningitis Vaccine Players: Market Share by Revenue in 2022
Figure 22. Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Prevent Meningitis Vaccine Sales Market Share by Country (2024-2034)
Figure 25. North America Prevent Meningitis Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. United States Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Prevent Meningitis Vaccine Sales Market Share by Country (2024-2034)
Figure 29. Europe Prevent Meningitis Vaccine Revenue Market Share by Country (2024-2034)
Figure 30. Germany Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Prevent Meningitis Vaccine Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Prevent Meningitis Vaccine Revenue Market Share by Region (2024-2034)
Figure 37. China Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Prevent Meningitis Vaccine Sales Market Share by Country (2024-2034)
Figure 45. Latin America Prevent Meningitis Vaccine Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Prevent Meningitis Vaccine Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Prevent Meningitis Vaccine Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Prevent Meningitis Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Prevent Meningitis Vaccine by Type (2024-2034)
Figure 55. Global Revenue Market Share of Prevent Meningitis Vaccine by Type (2024-2034)
Figure 56. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of Prevent Meningitis Vaccine by Application (2024-2034)
Figure 58. Global Revenue Market Share of Prevent Meningitis Vaccine by Application (2024-2034)
Figure 59. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2024-2034)
Figure 60. Prevent Meningitis Vaccine Value Chain
Figure 61. Prevent Meningitis Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed